Episode Details

Back to Episodes
Discussing PsA: Secukinumab & The Effect of Sex on the Long-Term Persistence of Targeted Therapies

Discussing PsA: Secukinumab & The Effect of Sex on the Long-Term Persistence of Targeted Therapies

Published 1 year, 9 months ago
Description
Join Professors Peter Nash, Philip Mease, Frank Behrens, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant topics in the field, namely the effect of sex on the long-term persistence of targeted therapies, as well as the impact of secukinumab on synovitis and enthesitis.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us